Whooping Cough Costs Greater for Patients With Chronic Respiratory Conditions?

Share on: 

In 2012, more cases of pertussis (whooping cough) were reported in the US than in any year since 1955. According to the Centers for Disease Control and Prevention, the number of reported cases of pertussis continues to be elevated: we are still experiencing a resurgence of this disease in the US.

Higher Risk/Limited Information

While it makes sense that individuals with chronic respiratory conditions may be at higher risk of infection, little has been reported on the economic burden of pertussis among this group. Four RTI Health Solutions researchers are co-authors on a study that looked at the economic burden pertussis creates among patients with preexisting conditions such as asthma, bronchitis, and emphysema compared to patients without these conditions.

Higher Economic Burden

The study found substantially higher costs (both overall and pertussis-related) during the three months following a diagnosis of pertussis for patients with chronic respiratory conditions. This result suggests that improving vaccination coverage among these high-risk patients may benefit health care systems.

If you have questions or would like more information about this study, please contact one of the authors using the links below.

Related Services:
Staff Members: